Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Investigating genetic interactions between RNA-binding proteins relevant to neurodegenerative disease in C. elegans

FY 2021-22

Summary
RNA binding proteins (RBPs) are a highly conserved group of post-transcriptional regulators, involved in processes that include mRNA polyadenylation, alternative splicing, nuclear export, and translation. As such, mutated RBPs have emerged as key players implicated in human genetic diseases. This is evident in a spectrum of neurodegenerative diseases which often share disease causative RBP genes. The RBPs, TAR DNA-binding protein 43 (TDP-43) and Fused in Sarcoma (FUS) have repeatedly been implicated in Amyotrophic Lateral Sclerosis (ALS), wherein these two predominantly nuclear-localized proteins become biased to the cytoplasm and aggregate. However, owing to the complex genetic etiology of human diseases like ALS, it is crucial to investigate the genetic interaction networks associated with RBPs, which could reveal genetic modifiers of disease. With its highly annotated genome and intact nervous system, C.elegansallows use of loss-of-function (LOF) techniques to generate large-scale genetic interaction networks, enabling identification of new interactors in key neurodevelopmental pathways. And with its rich suite of behaviours, C. eleganspermits modeling of neurodegeneration. We hypothesize that combinations of RBP LOF mutants and ALS-associated TDP-43/tdp-1 and FUS/fust-1 mutants, will reveal novel genetic interactions relevant to neuronal health and disease. To this end, we will use genome engineering techniques developed in our lab to conduct high throughput fitness assays and assess for synthetically enhanced interactions among double LOF mutants. These interactions can be probed in behavioural, morphological and transcriptomics contexts to inform translational genomics approaches of studying human genetic diseaseespecially as it concerns neurodegeneration.
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
466721
Name
Premachandran Sharanja
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigating genetic interactions between RNA-binding proteins relevant to neurodegenerative disease in C. elegans
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Als; C. Elegans; Crispr-Cas9; Disease; Gene Expression; Genetics; Loss-Of-Function; Neurodegeneration; Post-Transcriptional Gene Regulation; Rna-Binding Proteins
Abstract
RNA binding proteins (RBPs) are a highly conserved group of post-transcriptional regulators, involved in processes that include mRNA polyadenylation, alternative splicing, nuclear export, and translation. As such, mutated RBPs have emerged as key players implicated in human genetic diseases. This is evident in a spectrum of neurodegenerative diseases which often share disease causative RBP genes. The RBPs, TAR DNA-binding protein 43 (TDP-43) and Fused in Sarcoma (FUS) have repeatedly been implicated in Amyotrophic Lateral Sclerosis (ALS), wherein these two predominantly nuclear-localized proteins become biased to the cytoplasm and aggregate. However, owing to the complex genetic etiology of human diseases like ALS, it is crucial to investigate the genetic interaction networks associated with RBPs, which could reveal genetic modifiers of disease. With its highly annotated genome and intact nervous system, C.elegansallows use of loss-of-function (LOF) techniques to generate large-scale genetic interaction networks, enabling identification of new interactors in key neurodevelopmental pathways. And with its rich suite of behaviours, C. eleganspermits modeling of neurodegeneration. We hypothesize that combinations of RBP LOF mutants and ALS-associated TDP-43/tdp-1 and FUS/fust-1 mutants, will reveal novel genetic interactions relevant to neuronal health and disease. To this end, we will use genome engineering techniques developed in our lab to conduct high throughput fitness assays and assess for synthetically enhanced interactions among double LOF mutants. These interactions can be probed in behavioural, morphological and transcriptomics contexts to inform translational genomics approaches of studying human genetic diseaseespecially as it concerns neurodegeneration.
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Premachandran, Sharanja
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~